Managed Care Strategies for the Evolving Health Care Environment Live Webcast
To register, please click the link at the bottom of this page.
Live Webcast Dates
| Tuesday, June 23, 2015 | 12:00 PM - 1:30 PM EDT |
| Thursday, June 25, 2015 | 12:00 PM - 1:30 PM EDT |
| Tuesday, June 30, 2015 | 1:00 PM - 2:30 PM EDT |
Hot Topics Include:
- Recent clinical data affecting evidence-based treatment guidelines for MM
- Comprehensive care strategies involving effective communication methods
- Innovative oncology pharmacy benefit models integrated with specialty pharmacy management services
- Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for patients with multiple myeloma including: physicians, pharmacists, registered nurses, and case managers
Distinguished Faculty Presenters
|
David Frame, PharmD Hematology/Oncology and Bone Marrow Specialist University of Michigan Health System Assistant Professor of Pharmacy University of Michigan Assistant Professor of Pharmacology and Medicine Rush University |
|
James Kenney, Jr., RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care |
|
David H. Vesole, MD, PhD, FACP Co-Chief and Director of Research, Multiple Myeloma John Theurer Cancer Center Hackensack University Medical Center |
Program Overview
As novel agents become available to treat multiple myeloma (MM), treatment decision making is becoming more complex. In light of new drug developments as well as expanding uses of current agents, managed care organizations (MCOs) and other payer organizations need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. Emerging clinical and economic techniques, practical examples, and expert recommendations will be formulated to illuminate key learnings using MM as the therapeutic area of focus.
Educational Objectives
After completing this activity, the participant should be better able to:
- Evaluate recent clinical data affecting evidence-based treatment guidelines for MM
- Demonstrate the value of clinical pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes in the management of MM
- Implement comprehensive care strategies involving effective communication methods and innovative oncology pharmacy benefit models integrated with specialty pharmacy management services
- Provide accurate and appropriate counsel as part of the managed care treatment team
- Provide appropriate care and counsel for patients and their families
Agenda
| Opening Comments |
|
An Update on Practice Guidelines in Multiple Myeloma Management: Treatment Recommendations and Emerging Therapies
David H. Vesole, MD, PhD, FACP |
|
Designing and Implementing Clinical Pathways Initiatives to Reduce Treatment Variability and Improve Outcomes in Multiple Myeloma David Frame, PharmD |
|
Improving Multiple Myeloma Care via the Comprehensive Model: Attaining Provider Buy-in for Management Interventions and Specialty Pharmacy Services James Kenney, Jr., RPh, MBA |
| Audience Q&A Session |
|
Key Takeaways and Closing Comments Post-Activity Assessment and Evaluation |
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 |
Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - (0809-9999-15-181-L05-P)
Type of Activity: Application
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Nursing Continuing Education
Credit Designation
This educational activity for 1.5 contact hours is provided by Postgraduate Institute for Medicine.
Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A statement of credit will be issued only upon receipt of a completed activity evaluation form.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.x, and Google Chrome 10 and up
Fee Information
No additional fee is required to attend this CPE/CME/CNE activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
Click here to register